By attaching to estrogen receptors on breast cancer cells, the reactivated estrogens may promote the progression of estrogen-driven breast and ovarian cancer (Hu et al. 2023; Kwa et al. 2016; Sui et al. 2021). This evidence concerns the gene ESR1 and ovarian cancer.